WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer
- First Posted Date
- 2008-08-11
- Last Posted Date
- 2013-06-12
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 18
- Registration Number
- NCT00732082
- Locations
- 🇺🇸
Washington University, St. Louis, Missouri, United States
Sapropterin in Individuals With Phenylketonuria
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2018-06-18
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 45
- Registration Number
- NCT00730080
- Locations
- 🇺🇸
Washington University, Saint Louis, Missouri, United States
Oral Clofarabine for Acute Myeloid Leukemia
- First Posted Date
- 2008-08-04
- Last Posted Date
- 2014-11-11
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 25
- Registration Number
- NCT00727766
- Locations
- 🇺🇸
Washington University, St. Louis, Missouri, United States
Evaluating Genetic Factors That May Contribute to Elastin Function and the Development of Chronic Obstructive Pulmonary Disease
- Conditions
- First Posted Date
- 2008-07-30
- Last Posted Date
- 2018-06-18
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 255
- Registration Number
- NCT00725309
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy
- Conditions
- Interventions
- First Posted Date
- 2008-07-29
- Last Posted Date
- 2018-02-09
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT00723918
- Locations
- 🇺🇸
University of New York Downstate Medical Center, Brooklyn, New York, United States
🇺🇸University of Rochester, Rochester, New York, United States
🇺🇸University of California, San Diego, San Diego, California, United States
Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies
- Conditions
- Interventions
- First Posted Date
- 2008-06-23
- Last Posted Date
- 2017-03-07
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 26
- Registration Number
- NCT00703625
- Locations
- 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies
- Conditions
- Interventions
- First Posted Date
- 2008-06-23
- Last Posted Date
- 2013-05-24
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 28
- Registration Number
- NCT00703170
- Locations
- 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
Observational Study of Delayed Nausea and Vomiting
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2013-06-12
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 106
- Registration Number
- NCT00696280
- Locations
- 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)
- Conditions
- Interventions
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2016-10-13
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 52
- Registration Number
- NCT00691938
- Locations
- 🇺🇸
Washington University, St. Louis, Missouri, United States
Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2008-05-22
- Last Posted Date
- 2017-10-06
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 135
- Registration Number
- NCT00682786
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States